SCHEMBL4043016

SCHEMBL4043016

NC(=O)Oc1[nH]c2cnccc2c1Sc1cccc(F)c1

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ROCK2 O75116 2/20 0.40
CHUK O15111 3/20 0.39
MAP2 P11137 1/20 0.37
CDC7 O00311 2/20 0.36
TYMS P04818 1/20 0.36
HAO1 Q9UJM8 1/20 0.35
KDM5A P29375 1/20 0.34
TP53 P04637 1/20 0.34
RAB9A P51151 1/20 0.34
SMN1; SMN2 Q16637 1/20 0.34
KDM4C Q9H3R0 4/20 0.33
ICOSLG O75144 1/20 0.33
ICOS Q9Y6W8 1/20 0.33
EPHX1 P07099 1/20 0.33
CLK2 P49760 2/20 0.33
CDK5 Q00535 2/20 0.33
DYRK1A Q13627 2/20 0.33
CLK4 Q9HAZ1 2/20 0.33
KDM6B O15054 1/20 0.33
POLB P06746 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4035604 0.92 ACHE (0.40) ROCK2CHUKCDC7TYMSHAO1
SCHEMBL4035359 0.87 CSNK2A2 (0.42) ROCK2CHUKMAP2TYMSICOSLG
SCHEMBL4038757 0.87 MAP2 (0.46) ROCK2CHUKMAP2KDM5ASMN1; SMN2
SCHEMBL3839280 0.85 TUBB4A (0.44) TYMSEPHX1POLBTUBB4ATUBB
SCHEMBL4042867 0.85 TUBB4A (0.46) ROCK2CHUKCDC7ICOSLGICOS
SCHEMBL2049223 0.84 MAP2 (0.49) ROCK2CHUKMAP2CDC7TYMS
SCHEMBL4035517 0.80 TYMS (0.37) CDC7TYMSHAO1RAB9AEPHX1
SCHEMBL4039379 0.78 CHUK (0.42) ROCK2CHUKMAP2KDM5ASMN1; SMN2
SCHEMBL4040089 0.78 TUBB4A (0.41) CHUKMAP2SMN1; SMN2TUBB4ATUBB
SCHEMBL4036022 0.77 MAP2 (0.39) ROCK2CHUKMAP2KDM5ASMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1747220-B1 SUBSTITUTED 1H-PYRROLO[3,2-B, 3,2-C, AND 2,3-C]PYRIDINE-2-CARBOXAMIDES AND RELATED ANALOGS AS INHIBITORS OF CASEIN KINASE I EPSILON AVENTIS PHARMA INC (US) 2009-04-15 EP claimed